secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001688757-24-000084
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA approves Motiva SmoothSilk implants for breast augmentation; first new PMA since 2013
--------------------------------------------------------------------------------

- FDA approval for Motiva SmoothSilk Ergonomix and Round implants in primary and revision breast augmentation.
- Three-year clinical trial data: capsular contracture 0.5%, rupture 0.6%, infection 0.9% in primary augmentation cohort.
- First new breast implant PMA approved by FDA since 2013; nearly 4 million Motiva devices already delivered in 85+ countries.
- CEO Juan José Chacón-Quirós calls approval transformative for U.S. breast aesthetics, citing differentiated technology.
- Study conducted at 32 U.S. and 3 European centers; patient compliance at 92.4% at 3-year endpoint.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000084/0001688757-24-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000084/esta-20240926.htm
  HTML page:      https://secwatch.observer/filing/0001688757-24-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer